Annual Congress Berlin 2008

Saturday, 04.10.2008
Sunday, 05.10.2008
Monday, 06.10.2008
Tuesday, 07.10.2008
Wednesday, 08.10.2008

Citations should be made in the following way: Authors. Title. Eur Respir J 2008; 32: Suppl. 52, abstract number.

Material from 2008:

3952 Abstracts
658 Slide presentations
316 Webcasts
96 Handouts
1824 e-posters
316 Multimedia files

Material from 2008: Show

Therapy in thoracic oncology

Oral Presentation
Chairs: J-P. Sculier (Brussels, Belgium), E. Quoix (Strasbourg, France)

Download all media

Aerosoltherapy in lung cancer L. Guilleminault, A. Maillet, S. Pesnel, G. Paintaud, N. Congy-Jolivet, G. Thibault, H. Watier, S. Lerondel, L. Etienne, N. Heuze-Vourc‘h (Tours, Orleans, France)
Bevacizumab as first line treatment for advanced non-small cell lung cancer (NSCLC): a meta-analysis of randomised placebo-controlled trials (RCTs) M. Borges, J. Costa, S. Paulo, L. Pinheiro, A. Vaz-Carneiro (Lisboa, Portugal)
Safety analysis of anti-VEGF therapy bevacizumab (Bv) in patients (pts) with untreated advanced non-small cell lung cancer (NSCLC) in MO19390 (SAiL) trial D. Stroyakovskiy, C. Zhou, Z. Guan, W. Spengler, M. Wang, Y. D. Ko, C. K. Cheng, J. Mezger, A. Bearz, N. Pavlakis (Moscow, Russian Federation; Shanghai, Guangzhou, Beijing, China; Gerlingen, Bonn, Karlsruhe, Germany; Kowloon, Hong Kong; Aviano (PN), Italy
A blood-based test for epidermal growth factor receptor mutations in patients with non-small cell lung cancer M. Liu, C. He, J. Xu (Guangzhou, China)
Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer C. He, M. Liu, J. Xu (Guangzhou, China)
Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation (CRT) in patients with unresectable stage III non-small-cell-lung cancer (NSCLC): Cher@Nos trial P. Germonpré, A. Janssens, L. Van Moorter, D. Verresen, D. Galdermans, R. Devogelaere, H. Ottevaere, Y. Menstens, C. De Pooter, C. Goor (Antwerp, Aalst, Wilrijk, Oostende, Oudenaarde, Herentals, Belgium)
Radiotherapy planning based on positron emission tomography with fluordeoxyglucose in non small cell lung cancer – a pilot study A. Gröschel, U. Nestle, J. Fleckenstein, Y. Ploner, A. Schaefer-Schuler, S. Kremp, D. Hellwig, C. Rübe, C. M. Kirsch, G. W. Sybrecht (Homburg/Saar, Germany)
Radiofrequency ablation of primary lung tumours (4 years experience in the university hospital of Coimbra, Portugal) A. Szantho, A. Pego, G. Teixeira, F. Alves, A. Marques, M. Loureiro, M. F. Baganha (Coimbra, Portugal)